Lazard Asset Management
THRN

Lazard Asset Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Lazard Asset Management’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,659
Closed -$47K – 2549
2023
Q3 		$47K Buy
+4,659
New +$35.5K ﹤0.01% 1881

Lazard Asset Management's THRN Position: Q4 2023 in Review

Lazard Asset Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 4,659 shares — an estimated $47K sold.

Lazard Asset Management first reported a position in THRN in Q3 2023 and held it in 1 quarter. The position peaked at $47K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Lazard Asset Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Lazard Asset Management sold 4,659 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $47K.
  • Lazard Asset Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Lazard Asset Management's Thorne Healthtech, Inc. Common Stock position peaked at $47K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.